Search
for
Sort by
Research 30 of 1000+
- Creatine phosphokinase levels and isotretinoin therapy
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Unsuccessful Treatment of Alopecia Areata with Simvastatin/Ezetimibe: Experience in 12 Patients
- Haff disease associated with the ingestion of the freshwater fish Mylossoma duriventre (pacu-manteiga)
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Clinical Manifestations of Dermatomyositis
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Baricitinib: A Review in Severe Alopecia Areata
- Visual Improvement in a Child With Periorbital Plexiform Neurofibroma Treated With Selumetinib: Case Report and Literature Review
- Pharmacotherapy of plexiform neurofibromas in patients with neurofibromatosis type 1. Possible adverse events and their management
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study
- 307 Phenotypic-genotypic expansion of plectinopathy in a patient with muscular dystrophy and immune-mediated myasthenia gravis
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- [Hypothyroid myopathy in a young adult].
- Hair loss and cardiovascular health
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- 494 Epidermolysis bullosa pruriginosa, muscular dystrophy, and immune-mediated myasthenia gravis in a patient with homozygous nonsense PLEC mutation
- Secretory phospholipase A2-IIA overexpressing mice exhibit cyclic alopecia mediated through aberrant hair shaft differentiation and impaired wound healing response
- Integrated Lipidomics in the Secreted Phospholipase A2 Biology
- The atypical ‘hippocampal’ glutamate receptor coupled to phospholipase D that controls stretch‐sensitivity in primary mechanosensory nerve endings is homomeric purely metabotropic GluK2
- A network pharmacology-based approach to explore mechanism of action of medicinal herbs for alopecia treatment
- Resequencing Analyses Revealed Genetic Diversity and Selection Signatures during Rabbit Breeding and Improvement
- Targeted Inactivation of Gh/Tissue Transglutaminase II
- Interdisciplinarity traditional Chinese medicine microneedles in skin disease treatment: Recent advances and challenges
- Hair Follicle Signaling Networks: A Dermal Papilla–Centric Approach
- The Anti-atopic Lotions Containing Fucoidan Extracted from Ecklonia Cava Impact on Hairless Mice Atopic Dermatitis Skin
- Fundus changes in systemic lupus erythematosus
- Clinical Profile and Outcomes of Patients With Systemic Lupus Erythematosus